Wikisage, the free encyclopedia of the second generation, is digital heritage
Zonisamide: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (→LINK) |
||
Line 6: | Line 6: | ||
==LINK== | ==LINK== | ||
[https://www.ncbi.nlm.nih.gov/books/NBK1520/ MERFF] | [https://www.ncbi.nlm.nih.gov/books/NBK1520/ MERFF] : Myoclonic Epilepsy Associated with Ragged Red Fibers | ||
[http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits | [http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity] | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | ||
<references/> | <references/> | ||
{{wikidata|Q219957}} | {{wikidata|Q219957}} |
Revision as of 23:59, 25 August 2017
zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug.
It inhibitory action against carbonic anhydrase coul be related with perception of taste, and the novo lipogenesis. [1]
LINK
MERFF : Myoclonic Epilepsy Associated with Ragged Red Fibers
Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity